Portfolio Investments
Madryn invests in innovative and transformative companies that are driving the future of the healthcare industry
At Madryn, we are much more than a provider of capital. We are business builders and thoughtful strategic partners that possess extensive healthcare industry experience, knowledge and expertise. We take pride in collaborating and working alongside management teams to help them scale their companies, navigate operational challenges, and support their long-term growth.
Operating through 193 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy, an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 840,000 TMS treatments to over 24,000 patients struggling with depression.